FPRX
VOYA Investment Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-14,235
| Closed | -$536K | – | 2973 |
|
2021
Q1 | $536K | Sell |
14,235
-5,456
| -28% | -$205K | ﹤0.01% | 1991 |
|
2020
Q4 | $335K | Sell |
19,691
-16,700
| -46% | -$284K | ﹤0.01% | 2141 |
|
2020
Q3 | $171K | Sell |
36,391
-498
| -1% | -$2.34K | ﹤0.01% | 2204 |
|
2020
Q2 | $225K | Buy |
36,889
+17,767
| +93% | +$108K | ﹤0.01% | 2102 |
|
2020
Q1 | $43K | Hold |
19,122
| – | – | ﹤0.01% | 2515 |
|
2019
Q4 | $88K | Buy |
19,122
+4,992
| +35% | +$23K | ﹤0.01% | 2576 |
|
2019
Q3 | $55K | Hold |
14,130
| – | – | ﹤0.01% | 2494 |
|
2019
Q2 | $85K | Hold |
14,130
| – | – | ﹤0.01% | 2498 |
|
2019
Q1 | $189K | Hold |
14,130
| – | – | ﹤0.01% | 2284 |
|
2018
Q4 | $131K | Hold |
14,130
| – | – | ﹤0.01% | 2345 |
|
2018
Q3 | $197K | Hold |
14,130
| – | – | ﹤0.01% | 2341 |
|
2018
Q2 | $223K | Buy |
14,130
+1,536
| +12% | +$24.2K | ﹤0.01% | 2315 |
|
2018
Q1 | $216K | Hold |
12,594
| – | – | ﹤0.01% | 2282 |
|
2017
Q4 | $276K | Hold |
12,594
| – | – | ﹤0.01% | 2186 |
|
2017
Q3 | $515K | Hold |
12,594
| – | – | ﹤0.01% | 1862 |
|
2017
Q2 | $379K | Buy |
12,594
+1,097
| +10% | +$33K | ﹤0.01% | 2009 |
|
2017
Q1 | $416K | Hold |
11,497
| – | – | ﹤0.01% | 1827 |
|
2016
Q4 | $576K | Hold |
11,497
| – | – | ﹤0.01% | 1654 |
|
2016
Q3 | $603 | Hold |
11,497
| – | – | ﹤0.01% | 1626 |
|
2016
Q2 | $475K | Buy |
11,497
+1,835
| +19% | +$75.8K | ﹤0.01% | 1752 |
|
2016
Q1 | $393K | Hold |
9,662
| – | – | ﹤0.01% | 1844 |
|
2015
Q4 | $401K | Buy |
+9,662
| New | +$401K | ﹤0.01% | 1863 |
|
2015
Q3 | – | Sell |
-12,705
| Closed | -$316K | – | 2614 |
|
2015
Q2 | $316K | Hold |
12,705
| – | – | ﹤0.01% | 2228 |
|
2015
Q1 | $290K | Hold |
12,705
| – | – | ﹤0.01% | 2244 |
|
2014
Q4 | $343K | Hold |
12,705
| – | – | ﹤0.01% | 2181 |
|
2014
Q3 | $149K | Hold |
12,705
| – | – | ﹤0.01% | 2560 |
|
2014
Q2 | $198K | Buy |
+12,705
| New | +$198K | ﹤0.01% | 2566 |
|